Conclusions: This integrative computational–experimental workflow highlighted new promising natural PL inhibitors, laying the foundation for future development of safe, plant-derived anti-obesity therapeutics. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.